FreeStyle Libre

FreeStyle Libre is Abbott Laboratories' continuous glucose monitoring (CGM) brand. It is designed to help people with diabetes monitor glucose levels using a sensor-based system rather than relying exclusively on conventional fingerstick testing. Depending on the system and market, users can obtain glucose readings through a reader or compatible smartphone application, with the sensor collecting data from interstitial fluid beneath the skin. The brand's central proposition is to make glucose monitoring more convenient and informative in everyday life. FreeStyle Libre systems are built around a small wearable sensor and associated digital or reader-based tools. The sensor is intended to reduce the practical burden of repeated fingerstick checks and to provide users with a broader view of glucose patterns, including current readings and trends. This information can support diabetes self-management and discussions with healthcare professionals, although the appropriate use of any device depends on product labeling, local regulation, and clinical circumstances. FreeStyle Libre operates within Abbott's broader diabetes-care and health-technology portfolio. Its products are marketed internationally, and the brand's website presents the systems as tools for obtaining real-time glucose information without routine fingersticks. The portfolio includes multiple generations and configurations of Libre sensors, including the FreeStyle Libre 3 Plus identified on the official United States website. Product availability, features, reimbursement, smartphone compatibility, and indications can vary by country. As a brand, FreeStyle Libre is positioned around accessibility, convenience, continuous or near-continuous glucose visibility, and integration with digital health workflows. Its audience includes people living with diabetes, caregivers, and healthcare professionals, with the exact eligible population depending on the product and jurisdiction. The brand remains active under Abbott and is not an independent publicly listed company.

FreeStyle Libre was developed and commercialized as part of Abbott Laboratories' diabetes-care business. The brand is centered on flash or continuous glucose monitoring technology that uses a wearable sensor to collect glucose information from interstitial fluid. This approach addresses a longstanding usability challenge in diabetes management: the inconvenience of obtaining repeated measurements through traditional fingerstick testing. Rather than functioning as a standalone company, FreeStyle Libre is an Abbott brand and has evolved through a family of sensor-based systems, readers, software, and connected services. Its underlying user experience combines a small body-worn sensor with a reader or compatible mobile device. This allows users to view glucose readings and, where supported, understand direction and recent patterns. The precise capabilities and terminology differ among product generations and national markets. The brand's development reflects the broader shift in diabetes technology from isolated measurements toward more continuous data. By presenting glucose information over time, CGM systems can help users and clinicians identify patterns that may be missed by occasional testing. FreeStyle Libre's public positioning emphasizes convenience and access to real-time glucose information without routine fingersticks, while product labeling and local regulatory requirements determine how each system may be used. Abbott has expanded the Libre portfolio across markets and product generations. The current United States website highlights the FreeStyle Libre 3 Plus sensor as part of the brand's offering. The range may differ internationally in sensor duration, connectivity, indications, software functions, reimbursement, and compatibility with phones or readers. Consequently, FreeStyle Libre is best understood as a global product platform rather than a single uniform device. Today, FreeStyle Libre remains an active Abbott brand serving the diabetes-management market. It operates alongside other medical-device and digital-health offerings within Abbott, with its identity focused on wearable glucose sensing, actionable data, and more convenient daily monitoring. Publicly available reference material supplied for this entry does not establish a specific founding year, founder, headquarters city, executive roster, or dated corporate milestone for the brand.

A globally marketed continuous glucose monitoring brand focused on convenient, sensor-based glucose tracking and diabetes self-management.

• FreeStyle Libre continuous glucose monitoring systemsContinuous glucose monitoring

  A family of Abbott sensor-based glucose monitoring systems. Users wear a sensor that measures glucose in interstitial fluid and view readings through a compatible reader or mobile application, subject to the capabilities, labeling, and availability of the specific product and market. The systems are intended to provide a more convenient and data-rich alternative or complement to conventional spot-checking.

• FreeStyle Libre 3 PlusContinuous glucose monitoring sensor

  A newer sensor offering presented on the official FreeStyle Libre United States website. It belongs to the Libre CGM platform and is promoted as a way to obtain real-time glucose readings without routine fingersticks. Specific indications, sensor duration, connectivity, compatibility, and availability should be confirmed through current local product information.

1. FreeStyle Libre Continuous Glucose Monitoring | FreeStyle Libre US